ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials

A. Chang (Brisbane (QLD), Australia)

Source: International Congress 2022 – ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials

Webcast

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Chang (Brisbane (QLD), Australia). ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials. International Congress 2022 – ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.